These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34931766)

  • 1. Research progress in hepatitis B virus covalently closed circular DNA.
    Zhang X; Wang Y; Yang G
    Cancer Biol Med; 2021 Dec; 19(4):415-31. PubMed ID: 34931766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
    Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
    Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
    Peng B; Jing Z; Zhou Z; Sun Y; Guo G; Tan Z; Diao Y; Yao Q; Ping Y; Li X; Ren T; Li B; Li W
    J Virol; 2023 Jan; 97(1):e0171722. PubMed ID: 36475867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Interacting with Promyelocytic Leukemia Protein.
    Li Y; He M; Gong R; Wang Z; Lu L; Peng S; Duan Z; Feng Y; Liu Y; Gao B
    J Virol; 2022 Jul; 96(13):e0054622. PubMed ID: 35695580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach.
    Singh P; Kairuz D; Arbuthnot P; Bloom K
    World J Gastroenterol; 2021 Jun; 27(23):3182-3207. PubMed ID: 34163105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
    Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
    Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
    Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin inhibits hepatitis B virus covalently closed circular DNA transcription by enhancing the ubiquitination of HBx.
    Zhang Y; Li L; Cheng ST; Qin YP; He X; Li F; Wu DQ; Ren F; Yu HB; Liu J; Chen J; Ren JH; Zhang ZZ
    Front Microbiol; 2022; 13():850087. PubMed ID: 36033851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between SIRT1 and hepatitis B virus X protein in the activation of viral transcription.
    Deng JJ; Kong KE; Gao WW; Tang HV; Chaudhary V; Cheng Y; Zhou J; Chan CP; Wong DK; Yuen MF; Jin DY
    Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):491-501. PubMed ID: 28242208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome.
    Yang G; Feng J; Liu Y; Zhao M; Yuan Y; Yuan H; Yun H; Sun M; Bu Y; Liu L; Liu Z; Niu JQ; Yin M; Song X; Miao Z; Lin Z; Zhang X
    Theranostics; 2019; 9(24):7345-7358. PubMed ID: 31695772
    [No Abstract]   [Full Text] [Related]  

  • 11. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
    Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
    J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
    Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
    J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B.
    Naully PG; Tan MI; Agustiningsih A; Sukowati C; Giri-Rachman EA
    Ann Hepatol; 2024 Aug; 30(1):101533. PubMed ID: 39147134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesis.
    Jin XL; Hong SK; Kim H; Lee SK; Yi NJ; Lee KW; Suh KS
    Oncol Lett; 2019 Nov; 18(5):4984-4991. PubMed ID: 31612010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illuminating the Live-Cell Dynamics of Hepatitis B Virus Covalently Closed Circular DNA Using the CRISPR-Tag System.
    Ding J; Yi Z; Zai W; Wu M; Chen B; Cai Q; Zhang X; Yuan Z
    mBio; 2023 Apr; 14(2):e0355022. PubMed ID: 36840581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription.
    Salerno D; Chiodo L; Alfano V; Floriot O; Cottone G; Paturel A; Pallocca M; Plissonnier ML; Jeddari S; Belloni L; Zeisel M; Levrero M; Guerrieri F
    Gut; 2020 Nov; 69(11):2016-2024. PubMed ID: 32114505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
    Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
    J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B.
    Goh ZY; Ren EC; Ko HL
    World J Gastroenterol; 2021 Apr; 27(14):1369-1391. PubMed ID: 33911462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
    Zhong Y; Wu C; Xu Z; Teng Y; Zhao L; Zhao K; Wang J; Wang W; Zhan Q; Zhu C; Chen X; Liang K; Cheng X; Xia Y
    J Virol; 2022 Nov; 96(21):e0136222. PubMed ID: 36226986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.
    Saeed U; Kim J; Piracha ZZ; Kwon H; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.